Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Nov 5, 2010
Politics & Policy

Advisory committee votes on ulcer endpoints

BioCentury | Aug 9, 2010
Finance

IPOs Trimmed

Trius, NuPathe price scaled-down IPOs, Complete Genomics, Horizon join the queue
BioCentury | Aug 9, 2010
Finance

Moving on

BioCentury | Aug 3, 2010
Financial News

Horizon files for IPO

BioCentury | May 31, 2010
Clinical News

Duexa ibuprofen/famotidine regulatory update

BioCentury | May 27, 2010
Company News

FDA accepts Duexa NDA

BioCentury | Apr 12, 2010
Company News

Horizon Therapeutics, Nitec deal

BioCentury | Apr 12, 2010
Finance

Merging for an IPO

U.S.-Swiss merger by Horizon, Nitec aims to provide access to U.S. IPO market
Items per page:
1 - 8 of 8